You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 9,757,552


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,757,552
Title:Applicator for inserting an implant
Abstract: The invention pertains to an applicator (1) for inserting an implant, in particular a rod-like implant (2) containing an active substance, under the skin of a human or animal, comprising a housing (3), a cannula (6), a cannula holder (9), an implant (2) accommodated inside the cannula (6) and/or the cannula holder (9), a protective cover (7) for the cannula (6), and a mechanism (22, 23, 7) which, at least after the cover (7) has been removed from the cannula (6), secures the implant (2) inside the cannula (6) and/or cannula holder (9). The mechanism (22, 23, 7) disengages the implant (2) during insertion of the cannula (6) or after the cannula (6) has been inserted. Substantially no lateral force will be exerted during the expelling of the implant from the cannula.
Inventor(s): Jansen; Willem (Lieshout, NL), Tak; Maurice Petrus Wilhelmus (Hengelo, NL), Vertegaal; Hendricus Johannes (Hengelo, NL), Van Der Graaf; Iris Epkjen Hobo (Deventer, NL)
Assignee: MERCK SHARP & DOHME B.V. (Haarlem, NL)
Application Number:11/795,805
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;
Patent landscape, scope, and claims:

United States Patent 9,757,552: A Detailed Analysis of Scope and Claims

Overview of the Patent

United States Patent 9,757,552, titled "Applicator for inserting an implant," is a significant innovation in the field of medical devices. This patent, granted on September 12, 2017, pertains to an applicator designed for the insertion of implants, particularly those containing active substances, under the skin of humans or animals.

Inventor and Assignee

The patent was invented by Hendricus Johannes Vertegaal, and the assignee is not explicitly mentioned in the available sources, but it is likely assigned to a medical device company or a research institution[2].

Key Components of the Applicator

The applicator described in this patent includes several critical components:

  • Housing: The main body of the applicator.
  • Cannula: A hollow needle used for inserting the implant.
  • Cannula Holder: A mechanism to hold the cannula in place.
  • Implant: Specifically, a rod-like implant containing an active substance.
  • Protective Cover: A cover to protect the cannula.
  • Securing Mechanism: A mechanism to secure the implant inside the cannula and/or the cannula holder[1].

Functionality

The applicator is designed to facilitate the precise and safe insertion of implants. Here’s how it works:

  • The implant is accommodated inside the cannula or the cannula holder.
  • The protective cover ensures the cannula remains safe and sterile until use.
  • The securing mechanism prevents the implant from moving out of place during the insertion process.
  • Once the applicator is positioned correctly, the implant is released under the skin through the cannula[1].

Prior Art and Comparisons

This patent builds upon and differs from several prior art devices:

  • U.S. Pat. No. 5,906,599: This patent describes a device for delivering biological agents with a cannula and a displacement member. Unlike this, the current patent focuses on a rod-like implant and a more comprehensive securing mechanism[1].
  • U.S. Pat. No. 5,279,554: This patent involves a device for implanting objects like hormone pellets or electronic transponders with a hollow needle and an actuating rod. The current patent is more specialized for rod-like implants containing active substances[1].

Patent Claims

The patent claims are crucial in defining the scope of the invention. Here are some key aspects:

  • Independent Claims: These claims define the core elements of the applicator, including the housing, cannula, cannula holder, implant, protective cover, and securing mechanism.
  • Dependent Claims: These claims elaborate on the specific features and functionalities of the independent claims, such as the design of the cannula holder and the mechanism for securing the implant[1].

Patent Scope

The scope of the patent is determined by the breadth and clarity of its claims. Research suggests that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

  • Claim Length and Count: The patent scope can be measured by the length and count of independent claims. In this case, the claims are detailed enough to ensure clarity but not so broad as to encompass unrelated inventions[3].

Patent Landscape

The patent landscape for medical implant applicators is competitive and evolving:

  • Competing Patents: Other patents, such as U.S. Pat. No. 5,906,599 and U.S. Pat. No. 5,279,554, offer different solutions for implant insertion, but they do not cover the specific design and functionality of the current patent[1].
  • Litigation and Licensing: The patent's validity and scope could be subject to inter partes review or other legal challenges. For instance, the case IPR2018-00402 involves a different patent but highlights the potential for legal scrutiny in this field[5].

Applications and Impact

The applicator described in this patent has significant applications:

  • Contraceptive Implants: For example, etonogestrel, a long-acting synthetic progestin contraceptive, can be delivered via intradermal implants. This applicator could be used for such implants, ensuring precise and safe insertion[4].
  • Therapeutic Implants: The applicator can also be used for other therapeutic implants containing active substances, enhancing the delivery of various treatments.

Regulatory and Legal Considerations

The patent's legal status is active, with an estimated expiration date of July 28, 2030. This means that any use or manufacture of the applicator without permission from the patent holder could result in legal action[4].

Key Takeaways

  • The patent covers a specialized applicator for inserting rod-like implants containing active substances.
  • The design includes a housing, cannula, cannula holder, implant, protective cover, and securing mechanism.
  • The patent builds upon prior art but offers a unique solution for precise and safe implant insertion.
  • The scope of the patent is defined by its claims, which are narrow enough to ensure clarity and validity.
  • The applicator has significant applications in the field of contraceptive and therapeutic implants.

FAQs

What is the primary purpose of the applicator described in US Patent 9,757,552?

The primary purpose is to insert rod-like implants containing active substances under the skin of humans or animals in a precise and safe manner.

What are the key components of the applicator?

The key components include a housing, cannula, cannula holder, implant, protective cover, and a securing mechanism.

How does the applicator differ from prior art devices?

It differs by its specialized design for rod-like implants and the comprehensive securing mechanism to ensure the implant remains in place during insertion.

What is the estimated expiration date of the patent?

The estimated expiration date of the patent is July 28, 2030.

What are some potential applications of the applicator?

The applicator can be used for contraceptive implants like those containing etonogestrel and for other therapeutic implants containing active substances.

Sources

  1. US9757552B2 - Applicator for inserting an implant - Google Patents
  2. Hendricus Johannes Vertegaal Inventions, Patents and Patent ... - Justia
  3. Patent Claims and Patent Scope - SSRN
  4. Etonogestrel: Uses, Interactions, Mechanism of Action - DrugBank
  5. IPR2018-00402 - Unified Patents Portal

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,757,552

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Organon IMPLANON etonogestrel IMPLANT;IMPLANTATION 021529-001 Jul 17, 2006 DISCN No No ⤷  Subscribe ⤷  Subscribe Y PREVENTION OF PREGNANCY ⤷  Subscribe
Organon NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 13, 2011 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y PREVENTION OF PREGNANCY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,757,552

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
05100418Jan 24, 2005
PCT Information
PCT FiledJanuary 20, 2006PCT Application Number:PCT/EP2006/050346
PCT Publication Date:July 27, 2006PCT Publication Number: WO2006/077250

International Family Members for US Patent 9,757,552

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 055716 ⤷  Subscribe
Australia 2006207455 ⤷  Subscribe
Brazil PI0607013 ⤷  Subscribe
Canada 2593849 ⤷  Subscribe
China 101151062 ⤷  Subscribe
Cyprus 1123648 ⤷  Subscribe
Denmark 3417905 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.